Search

Your search keyword '"Kosma, Veli Matti"' showing total 1,444 results

Search Constraints

Start Over You searched for: Author "Kosma, Veli Matti" Remove constraint Author: "Kosma, Veli Matti"
1,444 results on '"Kosma, Veli Matti"'

Search Results

1. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

2. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies

3. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

5. A FinnGen pilot clinical recall study for Alzheimer’s disease

6. High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases

7. Rare germline copy number variants (CNVs) and breast cancer risk

8. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

10. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

11. FinnGen provides genetic insights from a well-phenotyped isolated population

12. Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

13. The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections

16. The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

17. Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women

18. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

19. Author Correction: FinnGen provides genetic insights from a well-phenotyped isolated population

20. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

21. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

22. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

23. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

25. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

26. Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

27. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

28. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

29. Age- and Tumor Subtype–Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

30. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression

31. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

32. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

33. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

34. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

35. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

36. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

38. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

39. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

40. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

41. Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

42. Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1

43. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

44. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

45. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

46. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

47. Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

48. Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions

Catalog

Books, media, physical & digital resources